Monjuvi 73535-0208-01

Generic: Tafasitamab-Cxix

Package NDC

73535-0208-01

Manufacturer: Incyte Corporation
Dosage Form: Injection, Powder, Lyophilized, For Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: August 5, 2020
Listing Expires: December 31, 2027
Application: BLA761163

Need to source Monjuvi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Tafasitamab	200 mg/5mL

Selected Package

73535-0208-01Selected

1 VIAL in 1 CARTON (73535-208-01) / 5 mL in 1 VIAL